by Siva Sai Kumar Rajana, Sampad Kumar Panda, Sridevi Jade, Chiranjeevi G. Vivek, A. K. Upadhayaya, Arti Bhardwaj, Sonam Jorphail & Gopi Krishna Seemala
We investigated the ionosphere response to the two severe geomagnetic storms in the ascending phase of solar cycle 25 which occurred during the 23-24 March 2023 (SYM-Hmin = −169 nT) and 23-24 April 2023 (SYM-Hmin = −233 nT) using a latitudinally aligned dense network of Global Navigation Satellite System (GNSS) receivers, magnetometers, and digisonde along the Indian longitude sector. The significant variations in TEC during the storm’s main and recovery phases are mainly linked to the influence of westward Disturbance Dynamo Electric Fields (DDEFs). During the initial phase of the March 23-24 geomagnetic storm, no changes in daytime TEC were observed, despite the storm occurring at noon time with a southward IMF Bz due to the influence of electron density in the top side ionosphere. Furthermore, both pre-reversal enhancement (PRE) and ionosphere irregularities are suppressed within two hours of their onset during the main phase of the March 23-24 storm, owing to the westward transition of zonal electric fields from an eastward direction. During the recovery phase of both storms, a daytime positive storm effect is observed over the dip equatorial region, while the beyond equatorial ionization anomaly (EIA) and mid-latitude regions perceived a negative ionospheric storm effect. This phenomenon is attributed to the influence of the dominant westward DDEFs during the period. Moreover, these DDEFs effectively inhibited the equinoctial manifestation of PRE effects and post-sunset ionospheric irregularities during the recovery phase of both storms. These findings are further confirmed with supporting information from TEC recorded by Swarm satellites, model-derived ionospheric electric fields, and thermospheric O/N2. The results from this study may advance the understanding of ionospheric response to severe geomagnetic storms under the prevailing westward DDEFs during the dayside recovery phase, complementing the global efforts for more reliable space weather modeling and prediction services.
Source: https://doi.org/10.1007/s10509-024-04268-9
by Priya Singh, Aditya Anand, Shweta Rana, Amit Kumar, Sujeet Kumar, Prabudh Goel, Krushna Chandra Gouda, Harpreet Singh
Introduction: The COVID-19 pandemic has caused widespread morbidity, mortality, and socio-economic disruptions worldwide. Vaccination has proven to be a crucial strategy in controlling the spread of the virus and mitigating its impact.
Objective: The study focuses on assessing the effectiveness of COVID-19 vaccination in reducing the incidence of positive cases, hospitalizations, and ICU admissions. The presented study is focused on the COVID-19 fully vaccinated population by considering the data from the first positive case reported until 20 September 2021.
Methods: Using data from multiple countries, time series analysis is deployed to investigate the variations in the COVID-19 positivity rates, hospitalization rates, and ICU requirements after successful vaccination campaigns at the country scale.
Results: Analysis of the COVID-19 positivity rates revealed a substantial decline in countries with high pre-vaccination rates. Within 1–3 months of vaccination campaigns, these rates decreased by 20–44%. However, certain countries experienced an increase in positivity rates with the emergence of the new Delta variant, emphasizing the importance of ongoing monitoring and adaptable vaccination strategies. Similarly, the analysis of hospitalization rates demonstrated a steady decline as vaccination drive rates rose in various countries. Within 90 days of vaccination, several countries achieved hospitalization rates below 200 per million. However, a slight increase in hospitalizations was observed in some countries after 180 days of vaccination, underscoring the need for continued vigilance. Furthermore, the ICU patient rates decreased as vaccination rates increased across most countries. Within 120 days, several countries achieved an ICU patient rate of 20 per million, highlighting the effectiveness of vaccination in preventing severe cases requiring intensive care.
Conclusion: COVID-19 vaccination has proven to be very much effective in reducing the incidence of cases, hospitalizations, and ICU admissions. However, ongoing surveillance, variant monitoring, and adaptive vaccination strategies are crucial for maximizing the benefits of vaccination and effectively controlling the spread of the virus.
Source: https://doi.org/10.3389/fpubh.2023.1272961
